Scarica l'app Stockscreener
16.76
9.33%
1.43
Dopo l'orario di chiusura:
16.85
0.09
+0.54%
Precedente Chiudi:
$15.33
Aprire:
$15.34
Volume 24 ore:
2.33M
Relative Volume:
1.70
Capitalizzazione di mercato:
$1.29B
Reddito:
$54.55M
Utile/perdita netta:
$-193.57M
Rapporto P/E:
-5.7993
EPS:
-2.89
Flusso di cassa netto:
$-181.86M
1 W Prestazione:
+30.94%
1M Prestazione:
+60.84%
6M Prestazione:
+71.37%
1 anno Prestazione:
-25.08%
Intervallo 1D:
$15.25
$16.97
Intervallo di 1 settimana:
$12.43
$16.97
Portata 52W:
$8.18
$23.00
Nurix Therapeutics Inc Stock (NRIX) Company Profile
Nome
Nurix Therapeutics Inc
Settore
Industria
Telefono
(415) 660-5320
Indirizzo
1700 OWENS STREET, SUITE 205, SAN FRANCISCO
Confronta NRIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRIX
Nurix Therapeutics Inc
|
16.76 | 1.55B | 54.55M | -193.57M | -181.86M | -2.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nurix Therapeutics Inc Stock (NRIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Mizuho | Outperform |
| 2025-03-17 | Iniziato | Leerink Partners | Market Perform |
| 2024-12-10 | Iniziato | BTIG Research | Buy |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-10-11 | Iniziato | Jefferies | Buy |
| 2024-09-06 | Ripresa | Robert W. Baird | Outperform |
| 2024-07-31 | Iniziato | Truist | Buy |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2023-03-09 | Iniziato | Barclays | Overweight |
| 2023-02-28 | Iniziato | Oppenheimer | Outperform |
| 2022-10-11 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-02-10 | Iniziato | Wells Fargo | Equal Weight |
| 2021-12-29 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-14 | Iniziato | SVB Leerink | Outperform |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2021-04-30 | Ripresa | Piper Sandler | Overweight |
| 2021-04-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-04-14 | Iniziato | Berenberg | Buy |
| 2020-11-19 | Iniziato | Robert W. Baird | Outperform |
| 2020-08-18 | Iniziato | JP Morgan | Overweight |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2020-08-18 | Iniziato | Piper Sandler | Overweight |
| 2020-08-18 | Iniziato | Stifel | Buy |
Mostra tutto
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
Nurix Therapeutics, Inc. $NRIX Holdings Trimmed by Primecap Management Co. CA - MarketBeat
Artisan Partners Limited Partnership Lowers Position in Nurix Therapeutics, Inc. $NRIX - MarketBeat
First Week of July 2026 Options Trading For Nurix Therapeutics (NRIX) - Nasdaq
How analysts rate Nurix Therapeutics Inc. stock todayQuarterly Profit Summary & Safe Capital Growth Stock Tips - newser.com
Nurix Therapeutics (NASDAQ:NRIX) Shares Up 10.4%Should You Buy? - MarketBeat
How sustainable is Nurix Therapeutics Inc. stock dividend payoutJuly 2025 Volume & Community Consensus Picks - newser.com
Patient Square Capital LP Has $4.70 Million Stake in Nurix Therapeutics, Inc. $NRIX - MarketBeat
Key metrics from Nurix Therapeutics Inc.’s quarterly dataWeekly Trade Recap & Weekly Return Optimization Alerts - newser.com
Will Nurix Therapeutics Inc. stock outperform Nasdaq indexTake Profit & Verified Momentum Watchlists - newser.com
How moving averages guide Nurix Therapeutics Inc. tradingTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Why Nurix Therapeutics Inc. stock is a must watch in 20252025 Market Overview & Daily Price Action Insights - newser.com
Can Nurix Therapeutics Inc. recover in the next quarter2025 Top Decliners & Reliable Price Breakout Alerts - newser.com
What to expect from Nurix Therapeutics Inc. in the next 30 daysBull Run & Fast Momentum Entry Tips - newser.com
Candriam S.C.A. Sells 326,547 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
Nurix Therapeutics Inc. stock daily chart insights2025 Institutional Moves & Fast Exit and Entry Trade Guides - newser.com
Signal strength of Nurix Therapeutics Inc. stock in tech scannersMarket Activity Summary & Safe Entry Point Alerts - newser.com
Applying chart zones and confluence areas to Nurix Therapeutics Inc.Quarterly Trade Review & Reliable Breakout Forecasts - newser.com
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Stock Rockets 30% As Investors Are Less Pessimistic Than Expected - simplywall.st
Visual trend scoring systems applied to Nurix Therapeutics Inc.2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Will Nurix Therapeutics Inc. stock sustain high P E ratiosWeekly Investment Report & Fast Moving Trade Plans - newser.com
Is Nurix Therapeutics Inc. stock a buy for dividend growthBond Market & Capital Protection Trading Alerts - newser.com
Is Nurix Therapeutics Inc. stock ready for breakoutEarnings Beat & Weekly High Potential Stock Alerts - newser.com
Analyzing Nurix Therapeutics Inc. with risk reward ratio chartsJuly 2025 Trends & AI Powered Buy and Sell Recommendations - newser.com
Full technical analysis of Nurix Therapeutics Inc. stockQuarterly Portfolio Report & Smart Swing Trading Techniques - newser.com
What analysts say about Nurix Therapeutics Inc stockAnalyst Downgrades & Small Budget Capital Gain - earlytimes.in
Nurix Therapeutics Inc Azioni (NRIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.38%
1.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):